24 May 2013
Keywords: fosamax, paget, disease, merck, co, alendronate, approved
Article | 11 March 1996
- Merck & Co's Fosamax (alendronate), approved last year for
treating osteoporosis, is also effective against Paget's disease,
according to a study ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 March 1996
23 May 2013
© 2013 thepharmaletter.com